Literature DB >> 23609138

Peroral endoscopic myotomy (POEM) is safe and effective in the setting of prior endoscopic intervention.

Ahmed Sharata1, Ashwin A Kurian, Christy M Dunst, Neil H Bhayani, Kevin M Reavis, Lee L Swanström.   

Abstract

OBJECTIVE: We aimed to determine the safety and feasibility of peroral endoscopic myotomy (POEM) in the setting of prior endoscopic interventions. PATIENTS: This study involves 40 consecutive patients undergoing POEM. INTERVENTION: POEM was performed for esophageal motility disorders, including achalasia, nutcracker with nonrelaxing lower esophageal sphincter (LES), hypertensive lower esophageal sphincter, and diffuse esophageal spasm. MAIN OUTCOME MEASURES: Outcome measures include length of procedure (LOP), intraoperative complications, and dysphagia relief.
RESULTS: Forty patients, with a mean age of 54 ± 19 years, underwent POEM. The pre-POEM intervention group consisted of 12 patients (nine achalasia, two nutcracker with nonrelaxing LES, and one diffuse esophageal spasm) who also had previous endoscopic treatment, while the pre-POEM non-intervention group consisted of 28 patients (22 achalasia, 3 hypertensive LES, 2 nutcracker with nonrelaxing LES, and 1 diffuse esophageal spasm). Ten patients had botox injections and two patients had large caliber balloon dilations prior to POEM. The median preoperative Eckardt score was 5 in the pre-POEM intervention group vs 6 in the pre-POEM non-intervention group (p value = 0.4). There was no statistical difference in the mean LOP (134 ± 43 vs 131 ± 41, p = 0.8) or the incidence of intraoperative complications (17 vs 3 %, p = 0.2) between the two groups. There was also no difference in the 6-month postoperative median Eckardt scores between the two groups (1 vs 1, p = 0.4).
CONCLUSION: POEM is safe and effective even following preoperative endoscopic large caliber balloon dilations or botox injection. These interventions do not seem to contribute to increased adverse intraoperative or postoperative clinical outcomes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23609138     DOI: 10.1007/s11605-013-2193-6

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  24 in total

1.  Effects of previous treatment on results of laparoscopic Heller myotomy for achalasia.

Authors:  M G Patti; C V Feo; M Arcerito; M De Pinto; A Tamburini; U Diener; W Gantert; L W Way
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

2.  Laparoscopic esophageal myotomy for achalasia: factors affecting functional results.

Authors:  Subrato Deb; Claude Deschamps; Mark S Allen; Francis C Nichols; Stephen D Cassivi; Brian S Crownhart; Peter C Pairolero
Journal:  Ann Thorac Surg       Date:  2005-10       Impact factor: 4.330

3.  Botox, dilation, or myotomy? Clinical outcome of interventional and surgical therapies for achalasia.

Authors:  Christian Alexander Gutschow; Ulrich Töx; Jessica Leers; Hartmut Schäfer; Klaus Ludwig Prenzel; Arnulf H Hölscher
Journal:  Langenbecks Arch Surg       Date:  2010-09-16       Impact factor: 3.445

4.  A stepwise approach and early clinical experience in peroral endoscopic myotomy for the treatment of achalasia and esophageal motility disorders.

Authors:  Lee L Swanström; Erwin Rieder; Christy M Dunst
Journal:  J Am Coll Surg       Date:  2011-10-13       Impact factor: 6.113

5.  The outcome of laparoscopic Heller myotomy for achalasia is not influenced by the degree of esophageal dilatation.

Authors:  Matthew P Sweet; Ian Nipomnick; Warren J Gasper; Karen Bagatelos; James W Ostroff; Piero M Fisichella; Lawrence W Way; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2007-08-21       Impact factor: 3.452

6.  Long-term outcomes of an endoscopic myotomy for achalasia: the POEM procedure.

Authors:  Lee L Swanstrom; Ashwin Kurian; Christy M Dunst; Ahmed Sharata; Neil Bhayani; Erwin Rieder
Journal:  Ann Surg       Date:  2012-10       Impact factor: 12.969

7.  Short and long term results of the laparoscopic Heller-Dor myotomy. The influence of age and previous conservative therapies.

Authors:  Giuseppe Paolo Ferulano; Saverio Dilillo; Michele D'Ambra; Ruggero Lionetti; Rossella Brunaccino; Domenico Fico; Domenico Pelaggi
Journal:  Surg Endosc       Date:  2007-08-19       Impact factor: 4.584

8.  Long-term outcome of laparoscopic Heller-Dor surgery for esophageal achalasia: possible detrimental role of previous endoscopic treatment.

Authors:  Giuseppe Portale; Mario Costantini; Christian Rizzetto; Emanuela Guirroli; Martina Ceolin; Renato Salvador; Ermanno Ancona; Giovanni Zaninotto
Journal:  J Gastrointest Surg       Date:  2005-12       Impact factor: 3.267

9.  Long-term outcomes confirm the superior efficacy of extended Heller myotomy with Toupet fundoplication for achalasia.

Authors:  A S Wright; C W Williams; C A Pellegrini; B K Oelschlager
Journal:  Surg Endosc       Date:  2007-03-01       Impact factor: 3.453

10.  Difficult myotomy is not determined by preoperative therapy and does not impact outcome.

Authors:  Sarah M Cowgill; Desiree V Villadolid; Sam Al-Saadi; Alexander S Rosemurgy
Journal:  JSLS       Date:  2007 Jul-Sep       Impact factor: 2.172

View more
  46 in total

Review 1.  Peroral endoscopic myotomy: An emerging minimally invasive procedure for achalasia.

Authors:  Yalini Vigneswaran; Michael B Ujiki
Journal:  World J Gastrointest Endosc       Date:  2015-10-10

2.  Peroral endoscopic myotomy is highly effective for achalasia patients with recurrent symptoms after pneumatic dilatation.

Authors:  Madhusudhan R Sanaka; George Khoudari; Malav Parikh; Prashanthi N Thota; Rocio Lopez; Niyati Gupta; Scott Gabbard; Monica Ray; Sudish Murthy; Siva Raja
Journal:  Surg Endosc       Date:  2020-06-18       Impact factor: 4.584

3.  Systematic review and meta-analysis: Efficacy and safety of POEM for achalasia.

Authors:  Lavinia A Barbieri; Cesare Hassan; Riccardo Rosati; Uberto Fumagalli Romario; Loredana Correale; Alessandro Repici
Journal:  United European Gastroenterol J       Date:  2015-08       Impact factor: 4.623

Review 4.  Safety and efficacy of POEM for treatment of achalasia: a systematic review of the literature.

Authors:  Oscar M Crespin; Louis W C Liu; Ambica Parmar; Timothy D Jackson; Jemila Hamid; Eran Shlomovitz; Allan Okrainec
Journal:  Surg Endosc       Date:  2016-09-15       Impact factor: 4.584

Review 5.  The Role of Botulinum Toxin Injections for Esophageal Motility Disorders.

Authors:  Jessica L Sterling; Ron Schey; Zubair Malik
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12

6.  Factors predicting the technical difficulty of peroral endoscopic myotomy for achalasia.

Authors:  Xiaowei Tang; Yutang Ren; Zhengjie Wei; Jieqiong Zhou; Zhiliang Deng; Zhenyu Chen; Bo Jiang; Wei Gong
Journal:  Surg Endosc       Date:  2015-12-10       Impact factor: 4.584

7.  The Outcomes and Quality of Life of Patients with Achalasia after Peroral Endoscopic Myotomy in the Short-Term.

Authors:  Xiao-Juan Liu; Yu-Yong Tan; Ren-Qi Yang; Tian-Ying Duan; Jun-Feng Zhou; Xiao-Ling Zhou; De-Liang Liu
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-07-07       Impact factor: 1.520

8.  Treatment of esophageal motility disorders based on the chicago classification.

Authors:  Carla Maradey-Romero; Scott Gabbard; Ronnie Fass
Journal:  Curr Treat Options Gastroenterol       Date:  2014-12

9.  Prior treatment does not influence the performance or early outcome of per-oral endoscopic myotomy for achalasia.

Authors:  Edward L Jones; Michael P Meara; Matthew R Pittman; Jeffrey W Hazey; Kyle A Perry
Journal:  Surg Endosc       Date:  2015-06-27       Impact factor: 4.584

Review 10.  Per-oral endoscopic myotomy: major advance in achalasia treatment and in endoscopic surgery.

Authors:  David Friedel; Rani Modayil; Stavros N Stavropoulos
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.